Aspyra Inc. (APYI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2008 | -2.84 Million USD | 12.92% |
| 2007 | -2.6 Million USD | -33.04% |
| 2006 | -1.95 Million USD | -77.7% |
| 2005 | -1.1 Million USD | -1153.62% |
| 2004 | -87.95 Thousand USD | -111.76% |
| 2003 | 747.93 Thousand USD | -49.5% |
| 2002 | 1.48 Million USD | 595.41% |
| 2001 | 212.95 Thousand USD | 189.58% |
| 2000 | 73.53 Thousand USD | -94.75% |
| 1999 | 1.4 Million USD | 333.33% |
| 1998 | -600 Thousand USD | -175.0% |
| 1997 | 800 Thousand USD | 0.0% |
| 1996 | 800 Thousand USD | 100.0% |
| 1995 | 400 Thousand USD | -20.0% |
| 1994 | 500 Thousand USD | 66.67% |
| 1993 | 300 Thousand USD | 0.0% |
| 1992 | 300 Thousand USD | 50.0% |
| 1991 | 200 Thousand USD | -33.33% |
| 1990 | 300 Thousand USD | 250.0% |
| 1989 | -200 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2009 Q3 | -613.46 Thousand USD | 23.92% |
| 2009 Q1 | -668.03 Thousand USD | 54.64% |
| 2009 Q2 | -806.3 Thousand USD | -20.7% |
| 2008 FY | - USD | 12.92% |
| 2008 Q1 | -719.8 Thousand USD | 26.58% |
| 2008 Q3 | -178.38 Thousand USD | 62.48% |
| 2008 Q2 | -475.49 Thousand USD | 33.94% |
| 2008 Q4 | -1.47 Million USD | -725.54% |
| 2007 Q4 | -980.36 Thousand USD | -294.01% |
| 2007 Q3 | -248.81 Thousand USD | 47.95% |
| 2007 FY | - USD | -33.04% |
| 2007 Q1 | -520.7 Thousand USD | -1103.0% |
| 2007 Q2 | -478.07 Thousand USD | 8.19% |
| 2006 Q4 | -43.28 Thousand USD | 85.69% |
| 2006 Q2 | -611.08 Thousand USD | 39.04% |
| 2006 Q1 | -1 Million USD | -28.62% |
| 2006 FY | - USD | -77.7% |
| 2006 Q3 | -302.48 Thousand USD | 50.5% |
| 2005 Q3 | -142.24 Thousand USD | -19.51% |
| 2005 FY | - USD | -1153.62% |
| 2005 Q4 | -779.33 Thousand USD | -447.9% |
| 2005 Q2 | -119.02 Thousand USD | -92.09% |
| 2005 Q1 | -61.96 Thousand USD | -198.71% |
| 2004 Q4 | 62.77 Thousand USD | -89.38% |
| 2004 Q1 | 208.06 Thousand USD | 275.95% |
| 2004 FY | - USD | -111.76% |
| 2004 Q3 | 590.81 Thousand USD | 299.61% |
| 2004 Q2 | 147.84 Thousand USD | -28.94% |
| 2003 Q3 | 85.8 Thousand USD | -67.04% |
| 2003 FY | - USD | -49.5% |
| 2003 Q4 | -118.25 Thousand USD | -237.81% |
| 2003 Q2 | 260.37 Thousand USD | 50.04% |
| 2003 Q1 | 173.53 Thousand USD | -23.97% |
| 2002 Q3 | 575.95 Thousand USD | 46.84% |
| 2002 FY | - USD | 595.41% |
| 2002 Q1 | 279.46 Thousand USD | 19.8% |
| 2002 Q2 | 392.24 Thousand USD | 40.36% |
| 2002 Q4 | 228.26 Thousand USD | -60.37% |
| 2001 Q4 | 233.26 Thousand USD | 249.07% |
| 2001 Q1 | -150.88 Thousand USD | 38.4% |
| 2001 FY | - USD | 189.58% |
| 2001 Q3 | -156.48 Thousand USD | -138.68% |
| 2001 Q2 | 404.54 Thousand USD | 368.11% |
| 2000 Q4 | -244.95 Thousand USD | -132.3% |
| 2000 Q2 | -466.11 Thousand USD | -407.57% |
| 2000 Q1 | 151.54 Thousand USD | -69.69% |
| 2000 FY | - USD | -94.75% |
| 2000 Q3 | -105.44 Thousand USD | 77.38% |
| 1999 Q3 | 200 Thousand USD | -60.0% |
| 1999 FY | - USD | 333.33% |
| 1999 Q4 | 500 Thousand USD | 150.0% |
| 1999 Q2 | 500 Thousand USD | 0.0% |
| 1999 Q1 | 500 Thousand USD | 150.0% |
| 1998 Q4 | 200 Thousand USD | 100.0% |
| 1998 Q1 | -500 Thousand USD | -600.0% |
| 1998 FY | - USD | -175.0% |
| 1998 Q2 | -300 Thousand USD | 40.0% |
| 1998 Q3 | 100 Thousand USD | 133.33% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | -50.0% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1997 Q2 | 200 Thousand USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 Q1 | 200 Thousand USD | -33.33% |
| 1996 Q2 | 100 Thousand USD | -50.0% |
| 1996 Q3 | 200 Thousand USD | 100.0% |
| 1996 FY | - USD | 100.0% |
| 1995 Q1 | 300 Thousand USD | -25.0% |
| 1995 FY | - USD | -20.0% |
| 1995 Q2 | -200 Thousand USD | -133.33% |
| 1995 Q4 | 300 Thousand USD | 50.0% |
| 1995 Q3 | 200 Thousand USD | 300.0% |
| 1994 FY | - USD | 66.67% |
| 1994 Q4 | 400 Thousand USD | 100.0% |
| 1994 Q3 | 200 Thousand USD | -33.33% |
| 1994 Q2 | 300 Thousand USD | 400.0% |
| 1994 Q1 | -100 Thousand USD | 0.0% |
| 1993 Q3 | -100 Thousand USD | -150.0% |
| 1993 Q2 | 200 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | -100 Thousand USD | 0.0% |
| 1993 Q1 | - USD | 100.0% |
| 1992 Q2 | 200 Thousand USD | 0.0% |
| 1992 Q1 | 200 Thousand USD | -83.33% |
| 1992 Q3 | -200 Thousand USD | -200.0% |
| 1992 Q4 | 100 Thousand USD | 150.0% |
| 1992 FY | - USD | 50.0% |
| 1991 Q4 | 1.2 Million USD | 1300.0% |
| 1991 FY | - USD | -33.33% |
| 1991 Q3 | -100 Thousand USD | -150.0% |
| 1991 Q2 | 200 Thousand USD | 0.0% |
| 1991 Q1 | - USD | -100.0% |
| 1990 Q3 | -100 Thousand USD | -150.0% |
| 1990 Q4 | 100 Thousand USD | 200.0% |
| 1990 Q2 | 200 Thousand USD | -81.82% |
| 1990 FY | - USD | 250.0% |
| 1990 Q1 | 1.1 Million USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q1 | 900 Thousand USD | 0.0% |
| 1989 Q2 | 900 Thousand USD | 0.0% |
| 1989 Q3 | -3 Million USD | -433.33% |
| 1989 Q4 | 1.1 Million USD | 136.67% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 65.812% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Cannabis Sativa, Inc. | -1.11 Million USD | -155.385% |
| CompuMed, Inc. | 690.19 Thousand USD | 512.401% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 101.338% |
| Cogstate Limited | 9.89 Million USD | 128.776% |
| CareView Communications, Inc. | -210.04 Thousand USD | -1255.143% |
| Craneware plc | 54.26 Million USD | 105.246% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 76.845% |
| Certive Solutions Inc. | -704.66 Thousand USD | -303.931% |
| Drug Free Solution, Inc. | -1.39 Million USD | -104.05% |
| DATATRAK International, Inc. | 2.72 Million USD | 204.317% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -4238.294% |
| Healixa Inc. | -6.32 Million USD | 54.965% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 127.992% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -568.962% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | -668.552% |
| Cannabiz Mobile, Inc. | -750.00 USD | -379414.0% |
| Mednow Inc. | -28.12 Million USD | 89.879% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -951.39% |
| MediXall Group, Inc. | -6.52 Million USD | 56.368% |
| Mitesco, Inc. | -11.96 Million USD | 76.208% |
| MobileSmith, Inc. | -13.83 Million USD | 79.43% |
| NantHealth, Inc. | -38.53 Million USD | 92.613% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | -67.63% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 76.45% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 76.473% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 316.992% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 3908.852% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -23261.417% |
| Renalytix Plc | -28.52 Million USD | 90.02% |
| Revium Recovery Inc. | -678 Thousand USD | -319.816% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -771269.919% |
| Vaso Corporation | 4.19 Million USD | 167.851% |
| Vynleads, Inc. | -235.72 Thousand USD | -1107.485% |